C-Bridge Capital logo

C-Bridge Capital

North America, New York, United States, New York

Description

C-Bridge Capital is a Chinese principal investment firm specialized in healthcare investments.

Investor Profile

C-Bridge Capital has backed more than 9 startups, with 3 new investments in the last 12 months alone. The firm has led 5 rounds, about 56% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Debt Financing rounds (top funding stages).
  • Majority of deals are located in United States, China, Singapore.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 3 rounds in the past year.

Stage Focus

  • Series B (33%)
  • Series C (22%)
  • Debt Financing (22%)
  • Series D (11%)
  • Series A (11%)

Country Focus

  • United States (44%)
  • China (33%)
  • Singapore (11%)
  • United Arab Emirates (11%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Pharmaceutical
  • Manufacturing
  • Oncology
  • Product Research
  • Medical Device
  • 3d Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does C-Bridge Capital frequently co-invest with?

HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 2
RTW Investments
North America, New York, United States, New York
Co-Investments: 2
Ally Bridge Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Matrix Partners China
Asia, Beijing, China, Beijing
Co-Investments: 2
BlackRock
North America, New York, United States, New York
Co-Investments: 1
CD Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CC
North America, New York, United States, New York
Co-Investments: 1
Qianhai Fund of Funds
Asia, Fujian, China, Shanzhen
Co-Investments: 1
Pavilion Capital
North America, New York, United States, New York
Co-Investments: 2
Tigermed
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1

What are some of recent deals done by C-Bridge Capital?

Bridgetech

Changning, Shanghai, China

Bridgetech is a global medical technology platform group focusing on the field of high-incidence chronic diseases.

Health CareInformation TechnologyMedical
Series AMar 25, 2025
Amount Raised: $137,790,393
Human Investments

Dubai, Dubai, United Arab Emirates

Human Investments is the exclusive distribution partner in Korea and China for Establishment Labs Holdings.

3D Technology
Debt FinancingDec 10, 2024
Amount Raised: $50,000,000
Synaptic Medical

Lake Forest, California, United States

Synaptic Medical is a medical device company.

BiotechnologyHealth CareMedical Device
Debt FinancingNov 28, 2024
Amount Raised: $40,000,000
RVAC Medicines

Singapore, Central Region, Singapore

RVAC Medicines is an mRNA platform company with a pipeline of novel products covering a wide range of disease areas.

BiotechnologyMedicalProduct Research
Series BApr 26, 2022
Amount Raised: $140,000,000
NiKang Therapeutics

Wilmington, Delaware, United States

NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.

BiotechnologyHealth CareMedicalOncology
Series CMay 26, 2021
Amount Raised: $200,000,000
AffaMed Therapeutics

New City, New York, United States

AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.

Biotechnology
Series BMar 30, 2021
Amount Raised: $170,000,000
Nuance Biotech

Shanghai, Shanghai, China

Nuance Biotech is a pharmaceutical company Based In China.

BiopharmaBiotechnologyPharmaceutical
Series DDec 7, 2020
Amount Raised: $181,000,000
GrayBug

Redwood City, California, United States

GrayBug is a biopharmaceutical company that develops transformative medicines for ocular diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Series CAug 20, 2019
Amount Raised: $80,000,000
CMAB BioPharm

Suzhou, Jiangsu, China

CMAB BioPharm is a Biopharmaceutical Service Firm.

BiopharmaBiotechnologyManufacturing
Series BApr 2, 2018
Amount Raised: $34,000,000